Guggenheim Capital LLC Adaptive Biotechnologies Corp Transaction History

Guggenheim Capital LLC

$10.6 Billion
Q1 2025

A detailed history of Guggenheim Capital LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 34,497 shares of ADPT stock, worth $317,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,497

Previous 40,845 15.54%

Holding current value

$317,372

Previous $245,000 4.49%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$6.07 - $8.66 $38,532 - $54,973	-6,348 Reduced 15.54%	34,497 $256,000
Q4 2024 Feb 13, 2025	SELL	$4.37 - $6.78 $44,106 - $68,430	-10,093 Reduced 19.81%	40,845 $245,000
Q3 2024 Nov 13, 2024	SELL	$3.37 - $5.12 $8,054 - $12,236	-2,390 Reduced 4.48%	50,938 $260,000
Q2 2024 Aug 14, 2024	SELL	$2.34 - $3.96 $3,619 - $6,126	-1,547 Reduced 2.82%	53,328 $193,000
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $5,685 - $9,475	-1,974 Reduced 3.47%	54,875 $176,000
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $1,214 - $1,870	-351 Reduced 0.61%	56,849 $278,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $155,922 - $259,563	30,754 Added 116.29%	57,200 $311,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $94,744 - $134,386	15,306 Added 137.4%	26,446 $177,000
Q1 2023 May 10, 2023	BUY	$7.8 - $10.11 $86,892 - $112,625	11,140 New	11,140 $98,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $6,357 - $12,391	-978 Reduced 4.99%	18,605 $132,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $5,632 - $12,962	880 Added 4.71%	19,583 $158,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $688 - $1,965	68 Added 0.36%	18,703 $260,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $1.32 Million - $1.93 Million	-52,384 Reduced 73.76%	18,635 $523,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $85,466 - $113,509	-2,847 Reduced 3.85%	71,019 $2.41 Million
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $26,098 - $36,117	810 Added 1.11%	73,866 $3.02 Million
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $638,338 - $1.16 Million	17,132 Added 30.63%	73,056 $2.94 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $2.52 Million - $3.66 Million	55,924 New	55,924 $3.31 Million

Others Institutions Holding ADPT

# of Institutions

246

Shares Held

156M

Call Options Held

44.3K

Put Options Held

47.8K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.31B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Adaptive Biotechnologies Corp Transaction History